Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis

Management of neuroendocrine liver metastasis (NELM) in the setting of unresectable disease is poorly defined and the role of debulking remains controversial. The objective of the current study was to define outcomes following non-curative intent liver-directed therapy (debulking) among patients with...